Académique Documents
Professionnel Documents
Culture Documents
Faizur Rahman
Professor of Ophthalmolgy
Peshawar Medical College
Peshawar
At the end of the session the students would
be able to:
Know various antibiotics and steroids used in Ophthalmic
practice.
Describe the rationale of using various drugs.
Mechanism of action , effects and side effects of these
drugs.
Know drug treatment of certain diseases
A chemical substance produced by one organism
causing the death of other bacterial cells i.e
penecillin and streptomycin.
After the introduction of synthetic agents these are
now called antibacterials.
As newer agents came up now a wide spectrum of
drugs are available called antimicrobials.
Difference between humans and microbes is
exploited to produce substances toxic to microbes
and harmless to humans.
The selective toxicity may be relative than
absolute.
Concentration of antimicrobials must be carefully
controlled.
INHIBIT BACTERIAL CELL WALL OR
ACTIVATE ENZYMES THAT DESTROY
BACTERIAL CELL WALL:
◦ PENICILLINS
◦ CEPHALOSPORINS
◦ BACITRACIN
◦ VANCOMYCIN
◦ KETOCONAZOLE
◦ MICONAZOLE
ALTER CELL WALL PERMEABILITY AND
LEAKAGE OF INTRACELLULAR CONTENTS
◦ POLYMYXINS
◦ NYSTATIN
◦ AMPHOTERICIN B
◦ COLISTIMETHATE
INHIBIT PROTEIN SYNTHESIS
◦ Tetracyclines
◦ Aminoglycosides
◦ Macrolides/Ketolides
◦ Clindamycin
◦ Chloramphenicol
DRUGS THAT BLOCK SPECIFIC METABOLIC
STEPS (Foleate inhibitors)
◦ SULFONAMIDES
◦ TRIMETHOPRIM
INHIBIT DNA DEPENDENT RNA POLYMERASE
◦ RIFAMPICIN
INHIBIT DNA DEPENDENT DNA SYNTHESIS
◦ QUINOLONES
ACT AS NUCLEIC ACID ANALOGUES
◦ ANTIVIRALS
Identify the infecting organism
Empiric therapy prior to identification
Determination of susceptibility
Barriers
Patient factors.
Safety of agent
Cost of therapy.
Chloramphenicol (Topical)
Anti-mycotics(Systemic and topical)
Aminoglycosides(Systemic and topical)
Sulphonamides(Systemic and topical)
Anti-virals (Systemic and topical)
Macrolides(Systemic)
Quinilones (Systemic and topical)
Cephalosporines (Systemic and topical)
STEROIDS
Mineralo corticoids
Glucocorticoids
Androgens
Beciomethasone
Betamethasone
Cortisone
Des oxy cortico sterone
Dexamethasone
Fludro cortisone
Hydrocortisone
Methyl prednisolone
Para methasone
Prednisolone
Prednisone
Triamcinolone
Promote normal intermediary metabolism:
Gluconeogenesis
Stimulate protein catabolism
Stimulate lipolysis
Increase resistance to stress by:
Raising blood glucose level
Modest rise in BP
Alter blood cell levels in plasma:
Decrease in eosinophils, basophils, monocytes and
lymphocytes by redistribution from circulation to
lymphoid tissue
Increase in the number of RBC, platelets, neutrophils
Anti inflammatory action: (Complex mechanism)
Suppression of immunity
Indirect inhibition of phospholipase A2
Alter other endocrine systems:
Decrease in ACTH and TSH
Increase in GH
Effects on other systems:
Increased production of gastric acid, pepsin
Effects on CNS
Bone loss
Myopathy
In the treatment of ocular inflammations and
immune related ocular diseases.
Act by suppressing the formation of arachidonic
acid and other mediators by induction mediators
like phospholipaze A2 and inhibitory protein
Lipocorteins
Prevent edema, Fibrin deposition, capillary
dilatation and proliferation, Leukocyte infiltration
and subsequent scarring.
Long acting/ Short acting/ Depot
Very potent
Potent
Moderately potent
Mild
Impaired wound healing/ Easy Bruising
Negative calcium balance/ Osteoporosis
Increased appetite/ Hyperglycemia/ Diabetes Mellitus
Euphoria/ Depression/ Psychosis
Hypertension
Edema (Sodium and water retension)/ Weight Gain
Peptic ulcers/ GI Hemorrhage/ GI Perforation
Hypokalaemia (Potassium depletion)
Hirsutism /Acne/ Coetaneous striae/ Amenorrhea
Myopathy (Gluconeogenesis)
Avascular Bone necrosis (Neck of femur)
Decreased Immunity
Cataract (PSC)
Steroid induced Glaucoma
Retinal Micro-Aneurysms
Papilloedema
Delayed Wound Healing
Mild Blephroptosis
Immune Suppression-Secondary Infections
◦ CANDIDA, TOXOPLASMOSIS, CMV, HSV,
Topical
Intralesional
Subconjunctival
Subtenon
Periocular
Intravitral
Intracameral
Systemic
oral
iv
Prenisolone (Topical and systemic)
Dexamethasone (Topical and systemic)
Betamethasone (Topical and systemic)
Hydrocortisone (Systemic only)
Loteprednol (Topical only) ( No IOP Rise)
Flouromethalone (Topical only) ( No IOP Rise)
Intra lesional in hemangioma and chalazion
Iv in optic neurirtis
Oral in dysthyroid ophthalmopathy. Corneal
transplant
Intravitreal in CRVO
Topical postoperative, uveitis, corneal transplant
Intracameral Per-op in children
The patient with orbital cellulitis should be promptly hospitalized for
treatment. Hospitalization should be continued until the patient is
afebrile and is clearly improved clinically.
Symptomatic; antipyretic, NSAIDS
Antimicrobials ;
◦ Ceftazidime 1 g tds , I/M
◦ Metronidazole 500mg tds, PO
◦ Vancomycin in case of allergy to the above mentioned
Surgical intervention in case of local abscess or unresponsive cases
Consultation with ENT specialist, neurosurgeon & paediatrician if
required
Specifically identified pathogens identified on
cultures.
Intravenous antibiotic therapy should be continued
for 1-2 weeks and then followed by oral antibiotics
for an additional 2-3 weeks.
Fungal infection requires intravenous antifungal
therapy along with surgical debridement.
Surgical drainage of an orbital abscess is indicated
if any of the following occurs: